Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.

about

Galectin-9: Diverse roles in hepatic immune homeostasis and inflammation.Shifting white pox aetiologies affecting Acropora palmata in the Florida Keys, 1994-2014.Evolving New Strategies for the Medical Management of Chronic Hepatitis B Virus Infection.Modeling the process of human tumorigenesis.

P2860

Q33923368-0BE5D07B-6A22-420F-B4CE-184CB62E5F06 Q36597046-39E0E91B-5022-4761-B478-CC963E4E58C1 Q37540212-7FBDCACE-F8C2-4349-8E14-AF235432EDF0 Q39328610-02DADABB-4AF8-4428-B3A7-3219C4539187

P2860

Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.

Item

http://www.wikidata.org/entity/Q36871021

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.

@en

type

Item

label

Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.

@en

prefLabel

Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.

@en

P1476

Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.

@en

P2093

2015 Princeton HCC Workshop participants

http://www.w3.org/2001/XMLSchema#string

Alison A Evans

http://www.w3.org/2001/XMLSchema#string

Anu Hosangadi

http://www.w3.org/2001/XMLSchema#string

Brian McMahon

http://www.w3.org/2001/XMLSchema#string

Chari Cohen

http://www.w3.org/2001/XMLSchema#string

Joan Block

http://www.w3.org/2001/XMLSchema#string

Morris Sherman

http://www.w3.org/2001/XMLSchema#string

Timothy Block

http://www.w3.org/2001/XMLSchema#string

W Thomas London

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

Management of hepatocellular carcinoma

Underestimation of liver-related mortality in the United States.

Novel natural mutations in the hepatitis B virus reverse transcriptase domain associated with hepatocellular carcinoma.

Hepatitis B virus: where do we stand and what is the next step for eradication?

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Effects of statins on the risk of hepatocellular carcinoma

1999-2001 Cancer mortality rates for Asian and Pacific Islander ethnic groups with comparisons to their 1988-1992 rates.

Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure.

Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome.

P31

scholarly article

P356

10.1093/JNCI/DJV359

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26626106

http://www.w3.org/2001/XMLSchema#string

P932

4857154

http://www.w3.org/2001/XMLSchema#string

Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.

about

P2860

P2860

Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P932